D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$301M |
| 3 |
Bausch Health
BHC
|
+$273M |
| 4 |
SPDR Gold Trust
GLD
|
+$231M |
| 5 |
Amazon
AMZN
|
+$218M |
Top Sells
| 1 |
LyondellBasell Industries
LYB
|
+$414M |
| 2 |
AGN
ALLERGAN INC
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$349M |
| 4 |
IBM
IBM
|
+$254M |
| 5 |
Microsoft
MSFT
|
+$247M |
Sector Composition
| 1 | Energy | 12.35% |
| 2 | Consumer Discretionary | 12.14% |
| 3 | Technology | 11.81% |
| 4 | Healthcare | 10.57% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Artivion
AORT
$1.94B
| $734K | ﹤0.01% |
70,803
+4,861
| +7% | +$50.4K |
|
|
MSB
1877
Mesabi Trust
MSB
$414M
| $733K | ﹤0.01% |
54,998
-13,346
| -20% | -$178K |
|
1878
BorgWarner
BWA
$9.34B
| $730K | ﹤0.01% |
13,714
-415,452
| -97% | -$22.1M |
|
|
AMPE
1879
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $730K | ﹤0.01% |
323
+25
| +8% | +$56.5K |
|
|
FWM
1880
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
| $727K | ﹤0.01% |
107,400
+7,141
| +7% | +$48.3K |
|
1881
Agios Pharmaceuticals
AGIO
$2.07B
| $726K | ﹤0.01% |
+7,696
| New | +$726K |
|
1882
Canadian Solar
CSIQ
$725M
| $726K | ﹤0.01% |
21,748
-250,084
| -92% | -$8.35M |
|
1883
Petrobras
PBR
$82.2B
| $726K | ﹤0.01% |
120,828
-3,297,603
| -96% | -$19.8M |
|
1884
Cadence Bank
CADE
$6.94B
| $724K | ﹤0.01% |
31,169
-127,119
| -80% | -$2.95M |
|
|
CORR
1885
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $724K | ﹤0.01% |
20,886
-9,771
| -32% | -$339K |
|
|
AUY
1886
DELISTED
Yamana Gold, Inc.
AUY
| $721K | ﹤0.01% |
200,925
-534,650
| -73% | -$1.92M |
|
1887
Old National Bancorp
ONB
$8.81B
| $720K | ﹤0.01% |
50,729
-58,739
| -54% | -$834K |
|
1888
Hillenbrand
HI
$1.75B
| $718K | ﹤0.01% |
23,275
-3,775
| -14% | -$116K |
|
1889
Vera Bradley
VRA
$63.7M
| $718K | ﹤0.01% |
44,251
-134,056
| -75% | -$2.18M |
|
1890
Omnicell
OMCL
$1.46B
| $717K | ﹤0.01% |
20,433
+6,133
| +43% | +$215K |
|
1891
Synaptics
SYNA
$2.67B
| $717K | ﹤0.01% |
+8,813
| New | +$717K |
|
1892
TransDigm Group
TDG
$72.5B
| $715K | ﹤0.01% |
3,267
-16,712
| -84% | -$3.66M |
|
|
KITE
1893
DELISTED
Kite Pharma, Inc.
KITE
| $715K | ﹤0.01% |
+12,400
| New | +$715K |
|
1894
Moelis & Co
MC
$5.44B
| $714K | ﹤0.01% |
23,711
+3,109
| +15% | +$93.6K |
|
1895
Viatris
VTRS
$11.9B
| $712K | ﹤0.01% |
+12,000
| New | +$712K |
|
1896
Five Below
FIVE
$8.05B
| $711K | ﹤0.01% |
+20,000
| New | +$711K |
|
|
PDLI
1897
DELISTED
PDL BioPharma, Inc.
PDLI
| $707K | ﹤0.01% |
100,495
+56,782
| +130% | +$399K |
|
1898
CNX Resources
CNX
$4.14B
| $706K | ﹤0.01% |
30,360
+5,880
| +24% | +$137K |
|
1899
NWPX Infrastructure, Inc. Common Stock
NWPX
$498M
| $704K | ﹤0.01% |
30,666
+6,838
| +29% | +$157K |
|
1900
Cross Country Healthcare
CCRN
$455M
| $703K | ﹤0.01% |
59,313
-1,076
| -2% | -$12.8K |
|